Search hospitals > Massachusetts > Boston
Beth Israel Deaconess Medical Center
Claim this profileBoston, Massachusetts 02215
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lymphoma
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
2097 reported clinical trials
157 medical researchers
Summary
Beth Israel Deaconess Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Lung Cancer, Prostate Cancer and other specialties. Beth Israel Deaconess Medical Center is involved with conducting 2,097 clinical trials across 1,398 conditions. There are 157 research doctors associated with this hospital, such as Gregory Cote, MD, Jon Arnason, MD, Andrea J Bullock, MD, and David J. Einstein, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
Stage III
ER positive
Top PIs
Gregory Cote, MDMassachusetts General Hospital5 years of reported clinical research
Studies Sarcoma
Studies Solid Tumors
19 reported clinical trials
27 drugs studied
Jon Arnason, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Expert in Lymphoma
Studies Chronic B-Cell Leukemia
15 reported clinical trials
24 drugs studied
Andrea J Bullock, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Studies Pancreatic Cancer
Studies Colorectal Cancer
14 reported clinical trials
34 drugs studied
David J. Einstein, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Studies Prostate Cancer
Studies Cancer
12 reported clinical trials
29 drugs studied
Clinical Trials running at Beth Israel Deaconess Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Deep Vein Thrombosis
Cancer
Blood Clot
Lymphoma
Pulmonary Embolism
Embolism
Multiple Myeloma
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
CDK 4/6 Inhibitor + Endocrine Therapy
for Breast Cancer
This research study is studying a drug as a possible treatment for ER-positive Breast Cancer The drug involved in this study is: -Ribociclib
Recruiting3 awards Phase 216 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Beth Israel Deaconess Medical Center?
Beth Israel Deaconess Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Lung Cancer, Prostate Cancer and other specialties. Beth Israel Deaconess Medical Center is involved with conducting 2,097 clinical trials across 1,398 conditions. There are 157 research doctors associated with this hospital, such as Gregory Cote, MD, Jon Arnason, MD, Andrea J Bullock, MD, and David J. Einstein, MD.
Where is Beth Israel Deaconess Medical Center located?
**Directions to Beth Israel Deaconess Medical Center, Boston:**
- **Main Entrance:** From I-90 E or I-93 N, take exit 16B towards Storrow Drive. Continue on Storrow Drive, take the Fenway/Kenmore exit, follow signs for Boylston Street Inner Belt, turn right onto Boylston Street, and then left onto Brookline Avenue. The medical center is located at 330 Brookline Avenue.
- **Emergency Room:** For emergency services, set your destination to 1 Deaconess Road.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Beth Israel Deaconess Medical Center, please call 617-667-5661. For specific billing questions, dial 866-306-7643. This program is available across the Beth Israel Deaconess network.
What insurance does Beth Israel Deaconess Medical Center accept?
Beth Israel Deaconess Medical Center (BIDMC) accepts a wide range of insurance plans, including but not limited to Aetna, AllWays Health Partners, Blue Cross MA, Cigna, Fallon Commercial, Harvard Pilgrim Healthcare, MassHealth, Medicaid, Medicare, TRICARE/Health Net Federal Services, Tufts Health Plans, and United Healthcare. The hospital also accommodates various Medicare Advantage plans, managed care plans, indemnity plans, and Mass Health. For a comprehensive list of accepted insurance providers, please refer to the Beth Israel Deaconess Care Organization provider directory.
What awards or recognition has Beth Israel Deaconess Medical Center received?
Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts, is renowned for its high-quality cardiovascular care, evidenced by six American Heart Association Get With The Guidelines achievement awards. As a leading academic medical center, BIDMC consistently ranks as a national leader among independent hospitals in National Institutes of Health funding, showcasing its significant research efforts and achievements.